Accurate detection of Parkinson’s disease (PD) through speech analysis holds great promise for early diagnosis and improved patient management. However, developing robust machine learning models is challenging due to the decentralized nature of medical…
Continue Reading
What You Should Know:
– Guidehealth, an AI-driven healthcare technology and services company, today announced a $10M strategic investment from Emory Healthcare.
– The funding is aimed at accelerating Guidehealth’s next phase of growth and strengthens…
Continue Reading
Source Credit: Boehringer Ingelheim & Eko Health
What You Should Know:
– Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced…
Continue Reading
Joseph Siemienczuk, MD, Medical Advisor for Clinical Solutions at Cedar Gate Technologies
Poorly managed and uncontrolled chronic diseases are the leading cause of death and disability in the United States, and represent a growing national…
Continue Reading
Seoul National University Hospital has recently unveiled a clinical decision support system for precision medicine treatment.WHY IT MATTERS
The SNUH POLARIS (Precision Oncology and Rare-Common Disease Supporter) is said to be the first of its…
Background: Musculoskeletal disorders are highly prevalent worldwide and contribute significantly to the overall burden of disease. Regular physical therapy with trained physiotherapists is recommended in guidelines. Recently, digital physical therapy offered by digital health…
Continue Reading
What You Should Know:
– Sleep Cycle, a sleep technology company, announced the commencement of a clinical study to validate its forthcoming smartphone-based feature for screening and monitoring obstructive sleep apnea (OSA).
– The feature will…
Continue Reading
Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for…
Continue Reading
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an…
Continue Reading
A new brain health service in Hong Kong utilises retinal imaging AI for predicting Alzheimer’s disease risk, touted as the first of its kind in the world.Humansa, a longevity-focused health and wellness centre, offers this new…
Continue Reading
